Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)

NCT05312177 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT05312177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05312177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS)
Lead sponsor
Carelon Research
Phase
Observational
Overall status
Completed
Start date
May 1, 2022
Completion date
December 31, 2023
Enrollment
273 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease, down syndrome